SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891293-19-000058
Filing Date
2019-08-01
Accepted
2019-08-01 16:59:36
Documents
59
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cti10q06302019.htm 10-Q 1157125
2 EXHIBIT 3.1 ex31certificateofamendment.htm EX-3.1 9098
3 EXHIBIT 31.1 ex311-ceo302q2fy19.htm EX-31.1 11034
4 EXHIBIT 31.2 ex312-cfo302q2fy19.htm EX-31.2 12128
5 EXHIBIT 32 ex32-ceocfo906q2fy19.htm EX-32 11923
  Complete submission text file 0000891293-19-000058.txt   4552661

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctic-20190630.xml EX-101.INS 780902
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctic-20190630.xsd EX-101.SCH 34006
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctic-20190630_cal.xml EX-101.CAL 81222
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctic-20190630_def.xml EX-101.DEF 114420
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctic-20190630_lab.xml EX-101.LAB 473509
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctic-20190630_pre.xml EX-101.PRE 258030
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28386 | Film No.: 19993407
SIC: 2834 Pharmaceutical Preparations